154 related articles for article (PubMed ID: 10619665)
1. Alpha-lipoic acid prevents 3,4-methylenedioxy-methamphetamine (MDMA)-induced neurotoxicity.
Aguirre N; Barrionuevo M; Ramírez MJ; Del Río J; Lasheras B
Neuroreport; 1999 Nov; 10(17):3675-80. PubMed ID: 10619665
[TBL] [Abstract][Full Text] [Related]
2. 2-Deoxy-D-glucose prevents and nicotinamide potentiates 3, 4-methylenedioxymethamphetamine-induced serotonin neurotoxicity.
Hervías I; Lasheras B; Aguirre N
J Neurochem; 2000 Sep; 75(3):982-90. PubMed ID: 10936179
[TBL] [Abstract][Full Text] [Related]
3. Different glial response to methamphetamine- and methylenedioxymethamphetamine-induced neurotoxicity.
Pubill D; Canudas AM; Pallàs M; Camins A; Camarasa J; Escubedo E
Naunyn Schmiedebergs Arch Pharmacol; 2003 May; 367(5):490-9. PubMed ID: 12684743
[TBL] [Abstract][Full Text] [Related]
4. 3,4-methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein.
Wang X; Baumann MH; Xu H; Rothman RB
Synapse; 2004 Sep; 53(4):240-8. PubMed ID: 15266556
[TBL] [Abstract][Full Text] [Related]
5. Serotonergic deficits and impaired passive-avoidance learning in rats by MDEA: a comparison with MDMA.
Barrionuevo M; Aguirre N; Del Río JD; Lasheras B
Pharmacol Biochem Behav; 2000 Feb; 65(2):233-40. PubMed ID: 10672974
[TBL] [Abstract][Full Text] [Related]
6. Ascorbic acid prevents 3,4-methylenedioxymethamphetamine (MDMA)-induced hydroxyl radical formation and the behavioral and neurochemical consequences of the depletion of brain 5-HT.
Shankaran M; Yamamoto BK; Gudelsky GA
Synapse; 2001 Apr; 40(1):55-64. PubMed ID: 11170222
[TBL] [Abstract][Full Text] [Related]
7. Unilateral infusion of a dopamine transporter antisense into the substantia nigra protects against MDMA-induced serotonergic deficits in the ipsilateral striatum.
Kanthasamy A; Sprague JE; Shotwell JR; Nichols DE
Neuroscience; 2002; 114(4):917-24. PubMed ID: 12379247
[TBL] [Abstract][Full Text] [Related]
8. The role of dopaminergic systems in the perinatal sensitivity to 3, 4-methylenedioxymethamphetamine-induced neurotoxicity in rats.
Aguirre N; Barrionuevo M; Lasheras B; Del Río J
J Pharmacol Exp Ther; 1998 Sep; 286(3):1159-65. PubMed ID: 9732373
[TBL] [Abstract][Full Text] [Related]
9. A study on the mechanisms by which minocycline protects against MDMA ('ecstasy')-induced neurotoxicity of 5-HT cortical neurons.
Orio L; Llopis N; Torres E; Izco M; O'Shea E; Colado MI
Neurotox Res; 2010 Aug; 18(2):187-99. PubMed ID: 19777321
[TBL] [Abstract][Full Text] [Related]
10. Endogenous 5-HT, released by MDMA through serotonin transporter- and secretory vesicle-dependent mechanisms, reduces hippocampal excitatory synaptic transmission by preferential activation of 5-HT1B receptors located on CA1 pyramidal neurons.
Mlinar B; Corradetti R
Eur J Neurosci; 2003 Sep; 18(6):1559-71. PubMed ID: 14511335
[TBL] [Abstract][Full Text] [Related]
11. Role of hyperthermia in the protective action of clomethiazole against MDMA ('ecstasy')-induced neurodegeneration, comparison with the novel NMDA channel blocker AR-R15896AR.
Colado MI; Granados R; O'Shea E; Esteban B; Green AR
Br J Pharmacol; 1998 Jun; 124(3):479-84. PubMed ID: 9647471
[TBL] [Abstract][Full Text] [Related]
12. (+/-)-3,4-Methylenedioxymethamphetamine administration to rats does not decrease levels of the serotonin transporter protein or alter its distribution between endosomes and the plasma membrane.
Wang X; Baumann MH; Xu H; Morales M; Rothman RB
J Pharmacol Exp Ther; 2005 Sep; 314(3):1002-12. PubMed ID: 15937150
[TBL] [Abstract][Full Text] [Related]
13. The hyperthermic and neurotoxic effects of 'Ecstasy' (MDMA) and 3,4 methylenedioxyamphetamine (MDA) in the Dark Agouti (DA) rat, a model of the CYP2D6 poor metabolizer phenotype.
Colado MI; Williams JL; Green AR
Br J Pharmacol; 1995 Aug; 115(7):1281-9. PubMed ID: 7582557
[TBL] [Abstract][Full Text] [Related]
14. In vivo evidence against clomethiazole being neuroprotective against MDMA ('ecstasy')-induced degeneration of rat brain 5-HT nerve terminals by a free radical scavenging mechanism.
Colado MI; O'Shea E; Esteban B; Granados R; Green AR
Neuropharmacology; 1999 Feb; 38(2):307-14. PubMed ID: 10218873
[TBL] [Abstract][Full Text] [Related]
15. Binge ethanol administration enhances the MDMA-induced long-term 5-HT neurotoxicity in rat brain.
Izco M; Orio L; O'Shea E; Colado MI
Psychopharmacology (Berl); 2007 Jan; 189(4):459-70. PubMed ID: 17047928
[TBL] [Abstract][Full Text] [Related]
16. Carrier-mediated release of serotonin by 3,4-methylenedioxymethamphetamine: implications for serotonin-dopamine interactions.
Gudelsky GA; Nash JF
J Neurochem; 1996 Jan; 66(1):243-9. PubMed ID: 8522960
[TBL] [Abstract][Full Text] [Related]
17. Increased anxiety 3 months after brief exposure to MDMA ("Ecstasy") in rats: association with altered 5-HT transporter and receptor density.
McGregor IS; Clemens KJ; Van der Plasse G; Li KM; Hunt GE; Chen F; Lawrence AJ
Neuropsychopharmacology; 2003 Aug; 28(8):1472-84. PubMed ID: 12700695
[TBL] [Abstract][Full Text] [Related]
18. The mechanisms involved in the long-lasting neuroprotective effect of fluoxetine against MDMA ('ecstasy')-induced degeneration of 5-HT nerve endings in rat brain.
Sanchez V; Camarero J; Esteban B; Peter MJ; Green AR; Colado MI
Br J Pharmacol; 2001 Sep; 134(1):46-57. PubMed ID: 11522596
[TBL] [Abstract][Full Text] [Related]
19. N-tert-butyl-alpha-phenylnitrone protects against 3,4-methylenedioxymethamphetamine-induced depletion of serotonin in rats.
Yeh SY
Synapse; 1999 Mar; 31(3):169-77. PubMed ID: 10029234
[TBL] [Abstract][Full Text] [Related]
20. 3,4-Methylenedioxymethamphetamine administration on postnatal day 11 in rats increases pituitary-adrenal output and reduces striatal and hippocampal serotonin without altering SERT activity.
Williams MT; Schaefer TL; Ehrman LA; Able JA; Gudelsky GA; Sah R; Vorhees CV
Brain Res; 2005 Mar; 1039(1-2):97-107. PubMed ID: 15781051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
